The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

The FDA has been cut off from producing compounded weight-loss drugs such as Ozempic, Mounjaro or Wegovy, the most effective ...

Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...

Continue reading to learn what compounded tirzepatide is and how it compares with Mounjaro. Drug compounding is a process in which a licensed pharmacist creates a custom alternative to an FDA ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

The FDA says compounding pharmacies have to stop making tirzepatide because the agency has declared the yearlong Zepbound shortage over. The deadline is Wednesday. The Agars are worried.

(1) District Court Decision on the End of Tirzepatide Shortage The lawful compounding of tirzepatide drugs was coming to an end when on October 2, 2024, FDA announced that the nearly two-year-long ...

Hollie Adams/Reuters In October, a compounding industry group, the Outsourcing Facility Association, filed a lawsuit against the FDA's decision that there was no longer a shortage of tirzepatide ...

So as of now, 503As can’t compound tirzepatide (at least on the basis of its being in shortage), since we’re past the February 18 deadline; and 503Bs have until March 19 to call it quits.

Larger outsourcing facilities, which are FDA-regulated and can create prescription-specific compounded drugs as well as bulk orders, must cease compounding, distributing or dispensing tirzepatide ...